Therefore, IL-1 is potentially a desirable molecular target for treating various diseases, including malignant tumors, metabolic syndromes, and autoimmune, infectious, autoinflammatory, and autoimmune diseases [192,193]. The gene discussed is IL1B; the disease is autoimmune disease.